Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
暂无分享,去创建一个
E. Thiel | C. Bartram | C. Pott | M. Kneba | H. Horst | M. Ritgen | D. Hoelzer | M. Brüggemann | T. Raff | N. Gökbuget | J. Droese | T. Flohr | S. Lüschen | U. Scheuring | M. Nakao | S. Lüschen